Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MDRX
BUYVeradigm Inc. · Healthcare · United States · $517M · Avg Vol: $163K/d
COMPANY DESCRIPTION
Veradigm Inc. provides healthcare technology solutions, including electronic health records (EHR), practice management, and payer/life sciences services. This established player in healthcare IT offers a broad suite of software and analytics solutions that integrate across the healthcare ecosystem. The company serves a diverse client base of physicians, hospitals, and pharmaceutical companies, facilitating interoperability and data-driven insights.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2024 | CAGR | TTM | 2025E | 2026E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|
| Revenue | 577.4M | 588.0M | — | 1.8% | 594.4M | 585.5M | 583.2M | -0.2% |
| EPS | 1.07 | -0.82 | -2.70 | — | -2.70 | — | — | — |
| Shares | 116.1M | 106.1M | — | -8.6% | 109.0M | — | — | — |
| Debt | 372.9M | 219.4M | — | -41.2% | 218.8M | — | — | — |
| Equity | 1.4B | 1.0B | — | -25.2% | — | — | — | — |
| Op CF | -76.6M | 115.6M | — | — | -20.0M | — | — | — |
| Inv CF | -12.7M | 585.1M | — | — | — | — | — | — |
| Fin CF | -258.9M | -444.9M | — | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MDRX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MDRX | Veradigm Inc.(you) | $517M | 66 | BUY |
| NRC | NRC Health | $474M | 72 | BUY |
| TALK | Talkspace, Inc. | $873M | 65 | HOLD |
| WEAV | Weave Communications, Inc. | $491M | 54 | HOLD |
| SLP | Simulations Plus, Inc. | $371M | 78 | BUY |
| OMDA | Omada Health, Inc. | $1.2B | 63 | HOLD |
| AMWL | American Well Corporation | $181M | 67 | BUY |
| GDRX | GoodRx Holdings, Inc. | $1.0B | 76 | BUY |
| PHR | Phreesia, Inc. | $632M | 47 | HOLD |
| EVH | Evolent Health, Inc. | $475M | 44 | HOLD |
Peer medians: ROE -25.5% · P/E 27.7x · Gross margin 50.5%